Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Teva Pharmaceutical Industries Ltd. Call Transcript 2008

Jul 23, 2008

7082_rns_2008-07-23_8d4d9ccb-6d9c-4ae4-8ea4-1f14344c6cb6.htm

Call Transcript

Open in viewer

Opens in your device viewer

_________ false

C003��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.7217Corporation no: 520013954Stock Exchange/Market: ���310381P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267554 , 03-9267652 Fax: 03-9267519E.mail address: [email protected] of transmission: 23/07/2008              Time of broadcast: 11:35 11:31:13

Reference: 2008-02-213348

Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on Transcript of teleconference held July 18, 2008, hosted by Teva Pharmaceutical Industries Limited and Barr Pharmaceuticals, Inc.

teleconferencetranscript180708_isa.pdf

Attached please find a report as filed with the U.S. authorities
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 21/07/2008
- - -
Name of the Signatory: : Desheh Eyal , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: .
Basel Telephone: 02-9411717 , Facsimile: 02-9411718 , E-mail: [email protected] 2